Andrés Coca-Pelaz, Juan P Rodrigo, Abbas Agaimy, Michelle D Williams, Nabil F Saba, Sandra Nuyts, Gregory W Randolph, Fernando López, Vincent Vander Poorten, Luiz P Kowalski, Francisco J Civantos, Mark E Zafereo, Antti A Mäkitie, Oded Cohen, Iain J Nixon, Alessandra Rinaldo, Alfio Ferlito
Poorly differentiated thyroid carcinomas (PDTC) are rare diseases; nevertheless, they account for the majority of deaths from non-anaplastic follicular cell-derived thyroid carcinomas. Establishing the diagnosis and treatment of PDTC is challenging given the low incidence and the lack of standardization of diagnostic criteria. These limitations hamper the ability to compare therapeutic modalities and outcomes between recent and older studies. Recently, the 5th edition of the classification of endocrine tumors has been published, which includes changes in nomenclature and the addition of the disease entity of "differentiated high-grade follicular cell-derived carcinomas"...
February 24, 2024: Virchows Archiv: An International Journal of Pathology